Navigation Links
Premier Research Appoints Troy W. McCall, Ph.D. as Chief Executive Officer
Date:10/1/2009

PHILADELPHIA, Oct. 1 /PRNewswire/ -- Premier Research Group Limited, the international pharmaceutical and medical device services company, announces the promotion of its current Chief Operating Officer, Troy W. McCall, Ph.D. to Chief Executive Officer. The appointment is part of the company's longstanding succession plan to support current CEO Dr. Simon Yaxley's desire to transition to an advisory role with the company's Board of Directors as Deputy Chairman.

Michael Barry, Non-Executive Chairman of the Board of Premier Research Group Limited, said, "On behalf of the Board, I would like to thank Dr. Yaxley for his efforts, commitment to excellence, and vision as CEO and Co-founder of Premier Research. Dr. McCall's commitment, drive, and deep understanding of the business make him the ideal successor to ensure that Premier Research maintains its outstanding track record of growth and customer service."

Dr. McCall's move into the CEO role is effective immediately and follows on the heels of nearly three years with the company as COO where he has led the successful integration of four acquisitions, established a global organization, and achieved year on year organic growth in excess of 20%. During Dr. McCall's tenure as COO, the company has initiated support of medical device trials in the U.S., launched a Functional Sourcing group, expanded the company's clinical research sites, and completed the company's first ever NDA submission on behalf a sponsor. Dr. McCall's leadership has firmly established Premier Research as a high quality, full-service, global CRO.

Dr. Simon Yaxley, Deputy Chairman, commented, "It is exciting and rewarding to have Troy stepping into the CEO role. This is what we have been working together towards and he deserves the recognition. I can think of no one more suited to continue to grow this successful company we, and many others, have worked hard to create. I also look forward to my continued involvement in the business as we continue to grow both organically as well as through acquisition."

Dr. McCall stated, "When I joined Premier Research, it was with the primary goal for the company to become the CRO of choice for global pharmaceutical and biotechnology companies. I am proud to say that we have completed several important milestones, and we are well on our way. This would not have been possible without the efforts and contributions of everyone in the organization. I am grateful for those efforts and look forward to continuing to exceed our client's expectations though our focus on operational excellence and unparalleled customer service."

About Premier Research

Premier Research is a leading global solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. They are leaders in clinical research for analgesia, neuroscience, oncology, and infectious disease and have a wealth of experience in medical device and pediatric research.

Premier Research has 30 offices and operates in more than 30 countries across North America and Europe employing more 1,200 clinical professionals dedicated first and foremost to fulfilling each client's requirements in a timely, accurate, and cost-effective manner. This includes a strong international network of monitors and project management professionals combined with regulatory, data management, statistical, scientific and medical experts, and staff at our well-established network of dedicated clinical sites.

www.premier-research.com

SOURCE Premier Research Group Limited


'/>"/>
SOURCE Premier Research Group Limited
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Premier Heart Launches Multifunction CardioGram(TM) (MCG) In Latin America and the Caribbean
2. Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress
3. Premier Research Announces Milestone Investigational New Drug Application
4. Premier Research Expands its Medical Device Operations to the United States
5. Premier Research Announces Milestone New Drug Application
6. Premier Research Honored as Clinical Research Team of the Year at 2008 GCPj Awards
7. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
8. CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year
9. Premier Micronutrient Launches Supplement for Hearing Health
10. Sangamo BioSciences Announces Research Collaboration With UCLA in Human Stem Cells Selected to Receive Clinical Research Award
11. Ganeden Biotech Announces Grants for Early Investigators to Research Probiotic GanedenBC30
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... 21, 2017 Cadence Design Systems, Inc. (NASDAQ: ... Tensilica ® Fusion F1 DSP is part of the ... The licensable IP targets SoCs designed for battery-powered sensor nodes ... leveraged the Fusion F1 DSP both to implement the IEEE ... trigger, audio identification and sensor fusion on a single DSP. ...
(Date:2/21/2017)... Research and Markets has announced the addition of the "Liver Cirrhosis ... ... Cirrhosis Drugs Price Analysis and Strategies - 2016, provides drug pricing data ... answers the following questions: What are the key ... positioned in the Global Liver Cirrhosis market? What are ...
(Date:2/21/2017)... Research and Markets has announced the addition of ... to their offering. ... latest research Rosacea Drugs Price Analysis and Strategies - 2016, provides drug ... research answers the following questions: What are the ... positioned in the Global Rosacea market? What are the ...
Breaking Medicine Technology:
(Date:2/21/2017)... Atlanta, GA (PRWEB) , ... February 21, 2017 ... ... firm, announced the acquisition of the predictive analytic firm Predixion’s Healthcare IT practice. ... of investment and is backed by giants including Accenture, GE Ventures, ...
(Date:2/21/2017)... ... February 21, 2017 , ... Along with Valentine’s Day, ... and make small changes that can lead to a lifetime of heart health. ... a cardiac emergency. , The Athletic Trainers’ Society of New Jersey (ATSNJ) ...
(Date:2/20/2017)... (PRWEB) , ... February 20, 2017 , ... Silverado today ... Healthcare to open and operate a state-of-the-art memory care community in Alexandria, Virginia. The ... on a site just outside of Old Town. , The three-story community with ...
(Date:2/20/2017)... ... 20, 2017 , ... The StayWell Company and VUCA Health ... patient health risks, foster behavior change and improve health literacy among patients. VUCA Health, ... a demonstration of its video capability at StayWell booth 3443 during HiMSS. , ...
(Date:2/20/2017)... ... February 20, 2017 , ... Houston dentist , Dr. ... care at his office, Antoine Dental Center. Emergency dentistry encompasses many treatments for ... at risk for serious complications and often experience severe pain. Not only does ...
Breaking Medicine News(10 mins):